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Abstract 
Background 
Mother-to-child transmission of Human Immunodeficiency Virus continues to be a major 
problem in Nigeria. Despite several initiatives, the number of infected pregnant women 
receiving Anti-Retroviral Therapy to prevent Mother-to-child transmission of the virus 
remains low in Nigeria. Evidence suggests that attitudes and perceptions of the pregnant 
women influence their use of Anti-Retroviral Therapy.  
Aim 
To understand the attitudes and perceptions of Human Immunodeficiency Virus   infected 
pregnant women towards the use of Anti-Retroviral Therapy for prevention of mother-to-child 
transmission in Nigeria. 
Method 
Twenty four Human Immunodeficiency Virus infected pregnant women were purposively 
selected from antenatal clinics. Women’s attitudes and perceptions towards the use of Anti-
Retroviral Therapy were explored using semi-structured in-depth interviews conducted in 
May/June 2016. All interviews were recorded, transcribed and analysed using thematic 
approach. 
Findings 
Overall, participants reflected a positive attitude about using Anti-Retroviral Therapy to 
prevent mother-to-child transmission and perceived the treatment as beneficial. The main 
themes identified included: perceived benefits of Anti-Retroviral Therapy; barriers to using 
Anti-Retroviral Therapy; threat from the susceptibility to the illness and the severity; 
perceived roles in treatment; and the negative behaviours of healthcare providers.  
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Conclusion 
The findings provide useful insights to inform Nigeria’s health policies on Anti-Retroviral 
Therapy. There is a need to educate the women on the benefits of the treatment as well as 
how they can cope with side effects and the daily regimen of the therapy during pregnancy. 
The findings also indicate the need for training healthcare providers on facilitative patient-
provider relationship. 
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Statement of Significance 
 
Problem 
 
What is already known What this paper adds 
Nigeria bears the highest 
burden of mother-to-child 
transmission of Human 
Immunodeficiency Virus 
(HIV) infection (32%).  Anti-
Retroviral Therapy is 
underutilized among 
infected pregnant women in 
Nigeria. 
There is a strong 
relationship between 
women’s attitudes and 
perceptions towards 
Anti-Retroviral Therapy 
and its use. 
Women’s attitudes and 
perceptions were associated with 
perceived benefits of and 
concerns about Anti-Retroviral 
Therapy. Barriers to ART included 
the belief that they are healthy, 
forgetfulness, waiting time at 
hospitals, side effects and taking 
treatment every day.  There is a 
need for more education about the 
effectiveness of ART and the 
importance of adherence to 
treatment.  
 
 
1. Introduction   
Mother-to-child-transmission (MTCT) of Human Immunodeficiency Virus (HIV) is one of the 
major challenges resulting from the HIV epidemic, accounting for 90% of all paediatric HIV 
infections worldwide.1,2 Globally, women constitute nearly half of those living with HIV and 
Acquired Immunodeficiency Syndrome (AIDS).1 The World Health Organization (WHO) 
estimated that approximately 18 million out of about 37 million people with HIV are women.3 
Biomedically, women appear to have higher risk of HIV infection than men, due to the 
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structure of the female reproductive tract.3,4 However, the growing feminization of the HIV 
epidemic may also be due to interrelated socio-cultural and economic factors that make 
women more vulnerable.5 As more women become infected there is also an increase in 
paediatric HIV through MTCT.2,6 Without intervention, HIV-positive mothers have about 15 to 
45% chance of transmitting HIV to their children via pregnancy, birth and breastfeeding.2 It is 
estimated that about 1.8 million children were living with HIV and 150,000 were infected in 
2015, every day about 400 children are infected with HIV, mainly through MTCT.7 Of these 
HIV-infected children, 91% live in Sub-Saharan Africa (SSA).8 In SSA, paediatric HIV is a 
major contributor to child mortality, with about one-third of infected infants dying within their 
first year of life.7,8 
In Nigeria, a total of about 260,000 children aged zero to 14 years were living with HIV/AIDS 
and about 180,000 deaths were due to AIDS in 2015; the majority (90%) being infected via 
MTCT, perhaps due to underutilisation of Anti-Retroviral Therapy (ART) among HIV-infected 
pregnant women in Nigeria.7-10 It was estimated by the joint United Nations Programme on 
AIDS (UNAIDS) that in 2015 only 30% of HIV-infected pregnant women utilised ART for 
prevention of MTCT in Nigeria.9 However, ART has been shown by clinical trials to be 
effective in preventing MTCT of HIV.11 The randomised trial conducted by French and 
American researchers in 1994 showed that when Zidovudine (a form of ART) was given to 
pregnant women, it reduced the MTCT risk, marking the first significant breakthrough in 
efforts to prevent MTCT of HIV.11 This study determined the effectiveness of Zidovudine 
monotherapy in preventing MTCT among 477 HIV positive pregnant women. The study’s 
participants received Zidovudine from 14 weeks of pregnancy and above until delivery and 
their infants were treated for six weeks. Among these participants, there was a 67% (95%CI) 
reduction in the risk of MTCT. Recent evidence suggests that combination therapy with two 
or more antiretroviral drugs is associated with a greater reduction of MTCT risk than 
monotherapy.1,12 A clinical trial (Kisumu Breastfeeding Study) conducted in Kenya reported 
reduced risk of MTCT when women received three-drug regimen from 34-36 weeks of 
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pregnancy until six months postpartum.12 MTCT rates at birth was 2.5%, at six weeks 
(4.2%), at six months (5.0%), at twelve months (5.7%), and at 24 months (7.0%) among 487 
live-births.12  Thus, the WHO recommends a lifelong combination therapy for pregnant and 
breastfeeding women (option B+). 1,8-10 
While the global prevalence of paediatric HIV is declining, the number of infections and 
deaths from HIV among Nigerian children is increasing.10 Since 2009, there has been a 
decrease in new infections of 76%, 69% and 65% in South Africa, Uganda and Ethiopia 
respectively.10 However, incidence of new infections in Nigerian children has only declined 
by 15% since 2009, thus, Nigeria now bears the highest number of new paediatric HIV 
infections in the world with 28% rate of MTCT.10 
The Nigerian Federal Ministry of Health (NFMH), supported by the WHO and the UNICEF, 
initiated the PMTCT programme in 2002 in six tertiary health institutions spread across the 
country.13 This response was in line with the global strategy for PMTCT that promotes the 
four-pronged procedure: preventing HIV infection in females of child bearing age as well as 
their partners, preventing unwanted pregnancies in HIV infected women, PMTCT, and giving 
support and care to HIV positive mothers, their young children and family members.9,113 
Despite explicit political will and practical means that were put in place to facilitate uptake, 
the number of Nigerian HIV-infected pregnant women receiving ART to prevent MTCT of 
HIV is not increasing as much as it was expected by public health authorities.13 Presently, 
only about three out of every ten HIV-infected pregnant woman receive ART to prevent 
MTCT.10,13 In order to achieve the United Nations’ target of eliminating MTCT, this gap in 
access to and usage of ART among pregnant women in Nigeria must be addressed. 
Research has established that there is a strong relationship between the use of ART and the 
women’s attitudes and perceptions towards ART.14,15 Evidence suggests that women are 
more likely to utilize ART when they hold favourable attitudes to ART, compared with those 
who have negative attitudes.14-16 In addition, Ezzy et al argued that HIV positive clients’ 
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(including women) attitudes towards ART exerts a greater influence on their choice to start 
ART than other aspects such as ill-health and clinical markers of HIV progression.14 For 
example, concerns that ART could harm the baby in South Africa,15 and doubts about ART 
being effective to prevent MTCT in Malawi,16 hindered HIV-infected pregnant women from 
using ART. 
Studies on PMTCT in Nigeria have focused mainly on knowledge and perception of MTCT 
and HIV testing and counselling, with ART mentioned as a method of PMTCT.8,17-20 
Furthermore, existing studies were conducted in the South-Western, 6, 20 North-Eastern20 
and South-Eastern zones of Nigeria.21 The only PMTCT study in the South-South zone 
focused on the perceptions of HIV testing and counselling for PMTCT.18  
There is a lack of studies focussing on attitudes and perceptions of ART for PMTCT in 
Nigeria. Therefore, this study aimed to understand HIV-infected pregnant women’s attitudes 
and perceptions to the use of ART for PMTCT in the Niger Delta region situated in the 
South-South zone of Nigeria. 
2. Methods 
2.1. Study design 
In-depth interviews were used to elicit information on the attitudes and perceptions of HIV-
infected pregnant women regarding the use of ART for PMTCT. An interview guide was 
designed to organise, guide and facilitate the interview discussions. The interview guide was 
based on a literature review and constructs of the health belief model (HBM). Two main 
domains were explored: perceptions and attitudes towards ART. Women were asked how 
they feel about using ART during pregnancy, how they are involved in taking their 
medications, concerns about ART and what discourage or encourage them to use ART. This 
interview guide was reviewed by a clinician and health service researchers and was 
amended as required. Before the study was conducted, the interview instrument was piloted 
with three participants, which resulted in minor amendment in the order of the questions.  
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2.2 Participants and Recruitment 
Participants included HIV-infected pregnant women aged 18 years and above who were 
attending antenatal clinics (ANCs) at three tertiary hospitals in Yenagoa and Uyo, capital 
cities of Akwa Ibom and Bayelsa states of the Niger Delta region of Nigeria during May and 
June 2016. A total of 24 participants were purposively sampled for the study. Pregnant 
women who met the inclusion criteria were approached by the nurse in-charge of ANCs in 
the study sites. The nurses informed them about the study and asked if they would like to 
participate in the research. Those who accepted to participate were introduced to the first 
author who provided them with information sheets, and asked them to sign a consent form.  
2.3 Data Collection 
Semi-structured in-depth interviews were conducted in May and June 2016 in English 
Language with a purposive sample of 24 participants in three tertiary hospitals located in the 
Niger Delta region of Nigeria. All the 24 interviews were conducted by the first author (PM) in 
a private room located in the selected hospitals. During the interviews, pregnant women’s 
perceptions and attitudes towards the use of ART for PMTCT were explored using open 
questioning and probing where necessary.21, 22 The interaction was free-flowing and flexible 
and the interviewee was allowed a great deal of leeway.23 The length of the interview was 
subject to the topics covered and the depth of the interviewees’ answers, with each interview 
taking between 30 to 60 minutes. All the interviews were audio recorded with a digital voice 
recorder. Additional field notes were taken. At the end of each interview, recordings were 
double-checked for quality, unanswered questions and to identify gaps, and any new leads 
were followed up in subsequent interviews. 
2.4 Data Analysis 
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All the 24 semi-structured recorded interviews were transcribed verbatim and were entered 
in NVivo 10. An inductive approach to thematic analysis which was data driven was 
adopted.23 The thematic analysis process followed the six phases outlined by Braun and 
Clarke.23 The transcripts were read repeatedly to achieve familiarity. Elements relevant to 
the objectives of the study were identified in the transcripts and labelled as codes. Coding 
and identification of themes was conducted without any intention of fitting them into a 
predetermined framework or structure as it was data driven.23 During the data analysis, 
codes were grouped into categories and categories into themes.23 All the coded data 
extracts were reviewed, and themes were further refined and defined.  
2.5 Ethical Consideration 
Ethics approval was obtained from the Institute for Health Research Ethics Committee, 
University of Bedfordshire and from the research and ethics committees of the following 
institutions in Nigeria:  Niger Delta University Teaching Hospital; the Federal Medical Centre, 
Yenagoa; and the University of Uyo Teaching Hospital. Participants were informed about the 
purpose, nature of the research, dissemination plans and their right to withdraw at any time 
from the study. Opportunity was given for questions to be asked. Written informed consent 
was obtained from all participants before commencement of the interviews. 
3. Findings 
A total of 24 in-depth interviews were conducted (Table 1). The age of participants ranged 
from 26 to 39 years. Most of the participants (n=20) were married, few were single (n=2) and 
cohabiting (n=2). In terms of level of education received, 14 participants received post-
secondary level of education and 10 were secondary school graduates. Majority (n=22) 
resided in urban areas, only two resided in semi-urban areas. In terms of the religion, all the 
participants were Christians. [INSERT TABLE1 HERE] 
The thematic analysis process resulted in the identification of five main themes: The main 
themes included: (1) perceived benefits of ART; (2) barriers to using ART; (3) threat from the 
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susceptibility to the illness and the severity; (4) perceived roles in treatment; and (5) negative 
behaviours of healthcare providers. The themes (including sub-themes) are presented in 
table 2. [INSERT TABLE2  HERE]. The following sub-sections present the themes and sub-
themes with illustrative quotes. 
3.1. Perceived Benefits of ART 
The theme covers the benefits that participants perceived about using ART for PMTCT. 
Participants perceived ART as beneficial in terms of reducing viral load, improving physical 
health, prolonging life and birthing HIV-free babies. These perceived benefits were a source 
of motivation to use ART for PMTCT.  
To reduce viral load 
Participants were motivated to use ART because of the view that ART will reduce the virus 
load in their system and will offer prevention from harm to themselves and the baby: 
“If I’m taking the drug, the drug will reduce the virus so that it will not harm me and 
my baby. If I don’t take them, it (HIV) will harm me. That’s why I’m taking them, so 
that at the end I will see good result. And as I’m taking them now I think things are 
improving” (P14). 
“It improves your immune system, then all those virus. It subdues the virus, don’t 
allow the virus to do you any harm” (P13).  
Improved physical health 
Participants expressed how their health improved after commencement of treatment with 
antiretroviral drugs. They regained control over their health which was threatened by the 
virus. Improved physical health was measured by their feelings and experiences: 
“Compared to the time I was sick before coming to the hospital and now. Since I 
started taking the drugs constantly, morning and evening, I feel better” (P19).  
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“What motivates me is that, I remember there was a time I was very sick. I was so 
lean, but now that I have started taking my drugs, anybody that sees me will say you 
are looking good. I know the drugs are working, so I always want to take them” (P9). 
HIV free baby 
Many accounts from the women indicated that  they were motivated to take ART during 
pregnancy because of the desire to have a healthy baby free of HIV: 
“When I discovered that I’m pregnant… (I thought) I need to fast (hurry) and start 
taking the drugs (as) I don’t want my baby to become infected as a result of this. I 
love my life very well, and my baby’s life too is very important to me. As I love my 
baby I will come and take it (ART) so that my baby will not be contaminated 
(infected)” (P2). 
 “I don’t have a choice for the sake of my baby. Even when I don’t want to (take 
ART), I tried to (take ART), no matter how hot I will feel. I tried to take for the sake of 
an innocent baby” (P19). 
“I know very well that if I stick to the drugs the child might not have it (HIV). The 
other way round, you know if I don’t (take ART) before realising it the baby would be 
infected” (P2). 
Healthier and longer life 
Another significant perceived benefit of ART that motivated participants to take ART was to 
lengthen lifespan. Participants were concerned about a long lifespan so that they can take 
care of their children and live longer than their mothers and this was another motivating 
factor for them: 
“I take it (ART) so I can live longer. The drug is helpful, makes people feel healthy. 
The drug is good…(help) people to be strong” (P13). 
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 “I take it (ART) because I wanted to be healthy. I wanted to live long and take care of 
my children” (P17). 
For other women, the will to live was a source of motivation to take ART. According to a 28 
year old participant: 
“Nobody wants to die, everybody wants to live. You want to live and survive, so you 
know the purpose that if you miss this drugs, maybe your status (CD4 count) will be 
coming down. The more you take this drug the more this virus drop. So you like 
yourself, you don’t want the virus to be rising, so you will be taking the drugs and 
going for what they say you should do” (P5). 
“I want to live. If not of this drug I would have died. The sickness almost takes my life. 
I don’t forget to take as far as they tell me not to miss” (P4). 
Hopefulness 
Participants view ART as a source of hope since there is no cure yet. According to these 
participants, taking ART helps to sustain their lives until a permanent solution comes:  
“I know that I have to take the drugs until solution will come. I don’t need to bother 
myself but I still pray. And I’m still taking the drugs, looking up to the end of this 
sickness” (P1) 
Participants were optimistic about the treatment; they believe that in the nearest future there 
will be a drug for permanent cure of HIV 
“I will do everything possible for me to take the drug consistent until there is a way 
out. …I’m made to understand, the doctor told me in ten years to come there will be a 
cure. So I will still be taking (ART) and waiting, that is it” (P2). 
13 
 
“My belief is that whatever has a beginning will surely have an end. As far as God still 
give that sense to trace this drug that we are taking now, I know one day they will still 
trace the drugs that will stop everything” (P5). 
3.2. Barriers to using ART 
This theme is centred on pregnant women’s assessment of the difficulties in taking ART for 
PMTCT. The sub-themes include: “I’m healthy”, forgetfulness, waiting time, side effects and 
taking ART every day.  
“I’m healthy” 
While the benefit of improving health from ART motivated participants to use ART, it also 
became a discouragement and reason for them to stop ART. Women stopped taking their 
medication since they were living a normal life without any health issue: 
“….because I’m healthy, I’m not sick. I always feel that I am okay, so I stop to take 
the drugs sometimes” (P17). 
“I got fed up with the drugs. Honestly speaking, I got fed up. I stopped since 2013 
until I came (for ANC). If not nurse said I should start, I wouldn’t have even start 
again,… because I don’t have any problem, I won’t lie you. I don’t have any problem; 
I was living like normal human being” (P8). 
Forgetfulness  
Participants in this study acknowledged missing their doses. Some participants attributed 
this to forgetfulness which results from being too busy with work:   
“Sometimes when I’m busy doing house work and I put my phone on alarm  ...the 
alarm will ring and stop. You know when it stop and I don’t go to take the drugs, I will 
forget” (P12) 
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“Let me be sincere, I do miss, at times. I used to forget the drugs, I won’t even 
remember” (P16). 
“I have missed taking my drugs some times. There were times when I am busy doing 
work that I forgot to take them” (P7). 
Waiting time 
Participants were also dissatisfied with the length of time spent to access ART services at 
the hospitals. Accessing ART services at the hospitals was a time consuming task. One of 
the participants said that she used to go to the hospital in the morning at 6 o’ clock and 
return after 5 o’clock in the evening. Another participant felt that her career was going to ruin 
as she has to wait for a whole day. The same participant also felt that the long waiting time  
meant she could not pick her children up from school : 
“I have a certain time to go and pick my kids in school, and for such time you are still 
here in the hospital you cannot do anything. I mean it is discouraging; having to come 
to clinic for a whole day, so I saw that it was going to ruin my career and whatever, 
so I stopped (accessing ART). It’s when I started at the clinic here (ANC) that the 
matron was telling me no, I shouldn’t have stopped” (P6). 
 “Sometimes I will come here 6 o’clock in the morning you will stay till 5 o’clock 
(evening). They waste time, the whole day; they will take the whole day. They waste 
time” (P14). 
Side effects 
Side effects were a major concern for pregnant women. Nearly half of the women expressed 
concerns about the side effects of ART on their health. Women complained about feeling hot 
at night, dizziness and weakness after taking antiretroviral drugs. They felt discouraged or 
skipped their medication in order to prevent side effects:  
“I feel very hot in the night because I take one  at night. If it continues like this, it’s 
affecting me. And when I go to bed, I feel very hot…my head will be very hot. I have 
15 
 
to wake up and shower. ….well, let me be sincere once in a while when it’s very hot 
and, like one period when my gen (generator) was bad, there was no light,  I can  
skip the drug for a while” (P19). 
“That first time, I was somehow discouraged because of the symptom (side effects)... 
I was like being discouraged and all that” (P2). 
“Though they told me it is not harmful. I have to try to cope with it, especially the 
dizziness, the weakness, and all that. But then, we have to consider the advantage, 
we really don’t have to give up” (P6). 
Taking ART everyday 
Even though participants perceived ART to be beneficial in preventing MTCT, taking the 
drug every day was not convenient for some of the participants.  Participants felt unhappy, 
annoyed and felt uncomfortable to take drugs every day: 
“What I’m not comfortable is this every day. It’s not really easy for someone to take 
drugs (ART) everyday but I’m trying with it. That’s the part I’m not comfortable with. 
At least if it is maybe take when you are sick... I don’t know how to put it but this one 
is just every day” (P18). 
“I’m not happy because before I wasn’t taking anything but now I’m taking drugs 
every day. I’m not happy” (P14). 
3.3. Threat from the susceptibility to the illness and the severity 
The participants perceived the threat  from their susceptibility to the illness  and the 
perceived severity. These sub-themes are described in the following sub-sections. 
Perceived susceptibility 
According to the HBM, perceived susceptibility refers to a person’s beliefs about the level of 
his/her risk of having a health problem.24 In this study, perceived susceptibility refers to HIV-
infected pregnant women’s perceptions of susceptibility of their unborn children to HIV. 
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Participants expressed the fear of transmitting HIV to their unborn children acknowledging 
that this is a possibility: 
“I’m afraid of this one (unborn child). I’m really afraid. I’m just praying, and I believe 
God. He should just punish me alone, and leave the child” (P3). 
“Sometimes I get concerned. That fear is there... to let your baby not come and suffer 
what you are suffering. I think sometimes that as far as the thing (HIV) is in my body 
it’s possible. I don’t want my baby to suffer what I’m suffering, so I always think of 
what to do that my baby will not have it” (P4). 
Perceived severity 
In this study, perceived severity is the perception of seriousness of the consequences of HIV 
in infants. Participants perceived that the consequences of HIV in infants will be disastrous 
and were in constant fear of  their children’s survival:  
“For a baby it can be serious because the baby will not withstand the things that will 
come out from it because she is still a baby… The baby will not be able to withstand 
the sickness that will come through the virus” (P5). 
“It will be very very serious, because I have seen one when I gave birth to my child. 
The mother gave birth to the child and died in two weeks’ time; the child was down 
and very ill” (P12). 
3.4. Perceived roles in treatment 
The participant had varied perceptions about the actions they had to undertake to make the 
treatment successful. The subthemes included: perceptions about diet and ART, and 
perception about support and ART. 
Perception about diet and ART 
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The participants perceived healthy eating as a role they must play while undergoing ART. 
They felt that food, especially fruits and vegetables, are necessary when taking strong drugs 
like antiretroviral drugs. They explained how the drugs can adversely affect HIV positive 
clients when taken without food. Some of them explained the significance of food in using 
ART by advocating that government should make provision for food and cash to HIV-
infected women to encourage them access and stay on treatment. The need for government 
to create organizations that will be in charge of distributing food and money to HIV-infected 
women living in rural areas was emphasised during the interviews. The extracts below 
support these points: 
“I have to take care of myself, eat good food and also take much fruits and vitamins 
to build up my immune system” (P6). 
“You know this our status; you eat more of fruits, vegetables while taking the drugs. 
Many people are taking the drugs but there is no food. I think government should 
have some organisation, like NGO that will go inside the village and distribute even if 
its food or cash. Those people are dying because you cannot be taking drugs with 
empty stomach” (P10). 
Perception about support and ART 
The husband’s involvement in access and uptake of ART was a common theme across all 
the married participants in this study. They felt that husbands should support them with 
domestic chores so that they can take their medicines. For instance, one of the participants 
stated: 
“…especially my husband, he’s helping a lot. When it’s almost time (to take ART) and 
I have not finished what I’m about to do, he’ll say keep it, go and take your drugs. He 
makes it easier for me. Either he’ll prepare the kids because we don’t have any 
house help, so it’s always easy for me to take (ART)” (P3). 
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Participants also acknowledged that disclosing their status to their husbands enhanced their 
uptake of ART. Participants believed that their husbands’ awareness of their treatment 
minimized the tendency of secretly taking ART. One of them explained how her husband 
reminds her when it’s time to take her medication: 
“My husband is my treatment partner; he reminds me when it’s time. You have 
problem when you hide it from your partner. Maybe when he’s there you’ll be trying to 
hide, when he’s out so that you can take it, it will delay you” (P1). 
“I really thank God for my husband, he will remind me of the time, you have not taken 
this (ART), it’s close to 9 pm, take your drug. So he makes my life, he makes me feel 
good” (P2). 
In addition to husbands supporting and reminding their wives to take ART, some participants 
use their phones as reminders in order not to forget to take ART. 
“For me I also use my phone. I always set my phone on reminder. When it’s that time 
I must take It (ART)” (P1). 
3.5. Negative behaviours of healthcare providers 
This theme is centred around the accounts from participants about how they felt as 
maltreated by healthcare providers while accessing PMTCT services. The maltreatment 
described by participants encompassed refusal to provide care, rudeness, verbal abuse,   
and the lack of sympathy and empathy.  
Refusal to provide care  
Participants described certain situations when they have been refused care when needed:  
“Do you know when I took the form to the place (office), those girls (healthcare 
providers) there did not even collect the form from me. They were just looking at 
me... So I waited for after like two or three minutes, the other one said madam, wait, 
or go and come back after. So I waited there, none of them attended to me” (P18). 
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“Sometimes they will not answer us, we will sit down there, they will not answer” 
(P14). 
Rudeness  
Participants expressed rude behaviours of nurses and other staff when they visit the hospital 
for PMTCT services: 
“Some (nurses) they look down on us. They will act as if we are not human beings. 
They will talk to us anyhow, they will sigh, they will hiss in the hospital” (P14). 
“This people (staff) will just look at you as if you are the worst thing. I don’t know how 
to put it, they will make you feel bad. Before you even come they will ask you, who 
asked you to sit down?” (P18). 
Participants pointed out that such rude behaviour is liable to discourage the desire to access 
and use ART in future: 
 “It’s discouraging when you talk to people anyhow. People will become tired and 
say, okay let me just give up. Instead of me to be suffering like this, coming to this 
clinic to take drugs every time and they will be talking to me (like this) because of this 
thing (HIV). … Let me abandon the drugs, it’s better I die. Let me abandon it and give 
up” (P14). 
Verbal abuse 
Verbal abuse was reported by participants in terms of doctors using negative words and 
shouting at them:  
“The doctor was telling me all kinds of painful things that I don’t have anything I’m 
getting pregnant. You don’t have anything and you are giving birth, nothing nothing, 
he was shouting at me” (P14). 
Lack of sympathy and empathy 
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Participants also expressed how unhappy they were with the lack of sympathy and empathy 
displayed by their doctors. One woman explained how the doctor put fear in her, telling her 
she will die during child birth:  
“I did my blood test and my blood level is low, is very low. When I come to the clinic 
this particular doctor that will attend to me…he will put fear in me more and more. He 
will say, this one your blood is low like this, if you give birth na casala (meaning 
death). I was scared” (P14). 
4. Discussion 
This qualitative study was based on 24 participants recruited through ANC nurses. The data 
was collected by conducting in-depth face-to-face interviews with HIV-infected pregnant 
women of Niger Delta region of Nigeria. Studies focussing on the uptake of ART based on 
HIV-infected pregnant women’s attitudes and perceptions in Nigeria are relatively scant, and 
the findings of this qualitative study provide insight into this area for contribution to policy and 
practice. Overall, women showed positive attitudes and perceptions towards ART and 
perceived it as beneficial in terms of improving physical health, reducing viral load, 
prolonging life and being able to prevent MTCT. ART was also reported to be a source of 
hope and survival. However, they had concerns about ART side effects, chances of having 
HIV negative or positive child and taking ART daily. This finding of women showing both 
positive attitudes and concerns about ART is in agreement with Richter et al study 25 which 
indicated that women had different concerns about ART even though they felt it was 
beneficial and was seen as a source of hope.  
The women in this study reported that the benefits of ART were a source of motivation to 
use ART for PMTCT. Participants felt that taking antiretroviral drugs will kill the virus in their 
bodies and protect them and their babies from the disease. It was observed from the 
interviews that pregnant women were motivated to take ART because they wanted to have a 
healthy baby. Other studies have found that women from South Africa and Malawi have 
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negative perceptions and attitudes regarding ART as they believed that ART can harm their 
babies or kill them doubting the effectiveness of the therapy to prevent MTCT. Some of them 
also believed that medical intervention for HIV was not required. 15,16 The desire to live 
healthier and longer motivated women to take ART in the present study. Women believed 
that ART improves their physical health and lengthen their lifespan. However, some women 
reported low adherence or stop taking ART when they felt  that their health improved. Similar 
findings were reported by McKinney et al. 26 as reason for non-adherence of ART in Malawi.  
Generally, the perceived benefits from ART as well as support from husbands/partners were 
central in stimulating positive attitude towards ART. This reinforces the view that government 
should promote an environment where women can disclose their status easily and get 
support from family members without the fear of stigmatization. This study found that support 
from family members especially husbands was valuable in using ART for PMTCT. This 
finding is in agreement with other studies26,27 which suggested that medical attention alone is 
not enough for successful ART delivery, as it also requires psychological and social support.  
Consistent with other studies28,29 women perceived healthy eating  has an important role in 
keeping them healthy while using ART for PMTCT. Women expressed the significance of 
food when taking ART and explained how hunger can lead to ART side effects. The women 
also advocated for food support and money to enhance the use of ART for PMTCT. 
Increased access to food  has been associated with increased use of ART for PMTCT.29 
Equally, food insecurity may be associated with discouragement to use ART for PMTCT.30,31 
Chop et al.31 specifically investigated the effect of food insecurity on uptake of ART among 
HIV-positive women. They found that food insecurity and hunger were common barriers for 
women to initiate and adhere to ART.  
The worry about side effects as a deterrent to taking ART has been reported by other 
studies that examined determinants of adherence. 31-33 They found that HIV positive clients 
missed antiretroviral doses in order to avoid side effects. Bam et al.33 assessed enablers and 
barriers of ART adherence and found that 61.9% of non-adherence respondents skipped 
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medication because of side effects. This suggests the need to provide counselling and 
educational intervention on how women can cope with the adverse effects of ART. As stated 
by Hawkins,34 knowledge of adverse effects of ART is vital for both patients and healthcare 
providers. 
This study also found that women reported a perception of threat (susceptibility and 
severity). Women perceived their unborn children as susceptible to transmitting HIV from 
them. They also perceived HIV as a serious condition in infants. Descriptions of susceptibility 
in this study were mainly elaborated through expressions of fear related to death of the child 
later in life, caring for a sick child and daily medication in childhood. These two perceptions 
were associated with motivation to use ART. Similarities can be drawn from the HBM, which 
proposes that people will take health-related actions (using ART), if they perceive 
themselves at risk of a condition, and also if the condition is perceived as severe.24 
Another common theme was the emphasis of the women on the significance of a good 
patient-provider relationship. The findings suggest that having a set of diverse and qualified 
staff is not enough to guarantee that healthcare professionals are sensitive to the individual 
care needs of women. Women in this study reported instances where providers were rude, 
disrespectful, lacked sympathy, refused to provide care and verbally abused them. Other 
studies have also reported similar findings about perceived negative behaviours of 
healthcare providers.35 It has been argued that  patients motivation to use and access 
treatment can be significantly influenced by negative attitudes shown by providers.36 The 
interviewed women’s expectations of their communications with providers were explicit, they 
crave for support, respect, warmth, feelings of confidence and trust, and also desired for 
providers who care about them. Boehme et al.36 opined that client-provider relationship is 
connected with client satisfaction and treatment, and also plays a key role in HIV positive 
clients’ lives and well-being. Chochinov 37 argued that healthcare professionals can 
positively impact on the experience of clients by displaying genuine empathy which will in 
turn promote the right conduct and effective communication. Providing healthcare with 
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empathy, that recognizes the individual beyond their requirement for care, is an important 
target of current policies.37 
Strengths and limitations  
This is the first qualitative study to explore attitudes and perceptions of HIV-infected 
pregnant women with regards to using ART for PMTCT in Nigeria. Employing a qualitative 
approach offered the opportunity for in-depth exploration of the area of interest. However, 
selection bias might have been introduced because of the purposive sampling method used 
in this study, and the selection of only ANC attendees at the time the data was collected. 
Therefore the findings may not be generalizable to the population group studied. 
Additionally, the study was conducted in the Niger Delta region of Nigeria which has 
predominance of Christians38 making the sample homogenous in terms of religion. It has 
been indicated that religious beliefs can influence people’s attitudes and perceptions towards 
ART.39 Hence the findings of this study may not be representative of pregnant women from 
other religious beliefs. 
In qualitative studies, researchers may influence the process because of the relationship that 
is built between the researcher and the participants. It is important to consider the likelihood 
of how researchers’ influence the research process when conducting qualitative research.40 
The first author, during the interviews ensured that questions asked were not leading; rather 
women had the opportunity to narrate their own story and were encouraged to explain in 
detail any important point raised for clarity. In addition, when many researchers are involved 
in a qualitative research, the design is strengthened and the analysis enriched. The research 
team in this study discussed every stage of the analysis process and interpretation of 
findings. 
5. Conclusion  
The findings from this study indicated that women were positive towards ART and perceived 
it as beneficial. However, women skipped their doses and in some cases stopped taking 
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ART for some time due to reasons such as the belief that they are healthy, forgetfulness, 
waiting time at hospitals, side effects and taking ART every day.  Factors such as the  threat 
from the susceptibility to the illness and the severity; their own perceived roles in treatment; 
and the negative behaviours of healthcare providers also influenced their uptake of ART.  A 
key recommendation is that there is a need for more education about the effectiveness of 
ART for PMTCT and the importance of adherence to treatment. This will help to scale up the 
uptake of ART for PMTCT and reduce MTCT of HIV in Nigeria. Even though women had 
access to ART, attitudes of healthcare providers may discourage them from future access. It 
is vital for healthcare providers to be trained on the importance of good client-provider 
relationship. Further research is required on how client-provider relationship as well as 
disrespect and abuse in maternity care impact on uptake of ART for PMTCT. The Nigerian 
PMTCT programme should incorporate food programme that will supply food to HIV-infected 
pregnant women both in urban and rural areas to enhance uptake of ART.  
Acknowledgement  
We are very grateful to [Name to be added] from [Name to be added] Hospital for their 
support during the data collection. We are also grateful to [Name to be added] for her 
support during the initial stage of this study. We would also like to thank the Matrons (nurses 
in charge) from [Name to be added] for their support in recruiting the participants. Special 
thanks to all the participants for their time and participation, without which this study would 
not have been possible. 
 
Disclosures  
We have not received any external funding for the conduct of this study. The authors certify 
that they have no personal or financial affiliation with other people or organizations that could 
bias or unseemly influence the content of the manuscript. We state specifically that there is 
no conflict of interest. 
25 
 
Abbreviations  
PMTCT: prevention of mother to child transmission of HIV; MTCT: mother to child 
transmission; ART: antiretroviral therapy; HIV: Human Immunodeficiency Virus; AIDS: 
Acquired Immune Deficiency Syndrome  
References  
1. World Health Organization. Interventions for preventing late postnatal mother-to-child 
transmission of HIV; c2015. Available from: 
http://apps.who.int/rhl/hiv_aids/Cd006734_Mnyanicn_com/en/  
2. World Health Organization HIV/AIDS: mother-to-child transmission of HIV; c2017 
Available from: http://www.who.int/hiv/topics/mtct/en/  
3. Abdool-Karim Q, Sibeko S, Baxter C. Preventing HIV infection in women: a global health 
imperative. Clin Infect Dis. 2010 May 15; 50(Suppl 3):S122–9. 
4. Ramjee G, Daniels B. Women and HIV in Sub-Saharan Africa. AIDS Res Ther. 2013; 
10(30):1-9. 
5. Boateng D, Kwapong G, Agyei-Baffour P. Knowledge, perception about antiretroviral 
therapy (ART) and prevention of mother-to-child-transmission (PMTCT) and adherence 
to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional 
study. BMC Women’s Health. 2013; 13 (2):1-8. 
6. Olugbenga-Bello A, Adebimpe W, Osundina F, Abdulsalam S. Perception on prevention 
of mother-to-child-transmission (PMTCT) of HIV among women of reproductive age 
group in Osogbo, Southwestern Nigeria. Int J Womens Health. 2013 Jul 11; 5:399-405. 
7. Joint United Nations Programme on AIDS. Children and HIV: fact sheet. 2016. Available 
from: http://www.unaids.org/sites/default/files/media_asset/FactSheet_Children_en.pdf 
8. Nigerian Federal Ministry of Health. National operational plan for the elimination of 
mother to child transmission (eMTCT) of HIV in Nigeria 2015 - 2016. 2014 Available 
26 
 
from: http://www.emtct-iatt.org/wp-content/uploads/2014/11/National-Operational-Plan-
for-EMTCT-Nigeria-Nov-2014.pdf (Accessed: 19 July 2015). 
9. Joint United Nations Programme on AIDS. Nigeria. 2016. Available from: 
http://www.unaids.org/sites/default/files/media/documents/UNAIDS_GlobalplanCountryfa
ctsheet_nigeria_en.pdf 
10. Joint United Nations Programme on AIDS. 2015 progress report on the global plan 
towards the elimination of new HIV infections among children and keeping their mothers 
alive. 2015 Available from: 
http://www.unaids.org/sites/default/files/media_asset/JC2774_2015ProgressReport_Glo
balPlan_en.pdf (Accessed: 10 March 2017). 
11. Connor EM, Sperling R, Gelber R, Kiselev P, Scott G, O'Sullivan M. et al. Reduction of 
maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine 
treatment. N Engl J Med. 1994 Nov 3: 331(18):1173-80. 
12. Thomas TK, Masaba R, Borkowf CB, Ndivo R, Zeh C, Misore A. et al. Triple-antiretroviral 
prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the 
Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med. 2011 Mar 29; 
8(3):e1001015.  
13. Nigerian Federal Ministry of Health. National guidelines for prevention of mother-to-child 
transmission of HIV (PMTCT). 2010 Available from: http://www.emtct-iatt.org/wp-
content/uploads/2013/04/Nigeria_National-PMTCT-Guidelines_2010.pdf (Accessed May 
2015). 
14. Ezzy D, Bartos M, de Visser R, Rosenthal D. Antiretroviral uptake in Australia: medical, 
attitudinal and cultural correlates. Int J STD AIDS. 1998 Oct; 9(10):579-86. 
15. Stinson K, Myer L. Barriers to initiating antiretroviral therapy during pregnancy: a 
qualitative study of women attending services in Cape Town, South Africa.  Afr J AIDS 
Res. 2012 Mar; 11(1):65-73. 
16. Levy J. Women's expectations of treatment and care after an antenatal HIV diagnosis in 
Lilongwe, Malawi. Reprod Health Matters. 2009 May; 17(33):152-61. 
27 
 
17. Dinwoke V, Okafor C. Prevention of mother to child transmission (PMTCT) of human 
immunodeficiency virus (HIV): perception and practice of antenatal clients in Newi, 
south-east Nigeria. Trop J Obstet Gynaecol. 2013; 30 (2):1-6. 
18. Mezie-Okoye M, Tobin-West C. Perception of routine HIV counselling and testing for 
prevention of mother-to-child transmission of HIV infection in Rivers State, South-South, 
Nigeria. Niger Med Pract. 2010; 57(1-2):1-8. 
19. Moses A, Chama C, Udo S, Omotora B. Knowledge, attitude and practice of ante-natal 
attendees toward prevention of mother to child transmission (PMTCT) of HIV infection in 
a tertiary health facility, Northeast-Nigeria. East Afr J Public Health. 2009 Aug; 6(2):128-
35. 
20. Owoaje E, Omidokun A, Ige, O. Knowledge and perception of prevention of mother to 
child services amongst pregnant women accessing antenatal clinic in a primary health 
care centre in Nigeria: original research. Afr. J. Prim. Health Care Fam. Med. 2012; 
4(1):1-7. 
21. Creswell J, Plano Clark V. Designing and conducting mixed methods research. 2nd ed. 
London: Sage; 2011. 
22. Morris A. A practical introduction to in-depth interviewing. London: Sage; 2015. 
23. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006; 
3(2):77-101. 
24. Janz N, Becker M. The health belief model: a decade later. Health Education Quarterly. 
1984; 11(1):1-47. 
 
25. Richter D, Sowell R, Pluto D. Attitudes toward antiretroviral therapy among African 
American women. Am J Health Behav. 2002 Jan-Feb; 26(1):25-33. 
26. McKinney O, Modeste N, Lee J, Gleason P. Predicting Malawian women’s intention to 
adhere to antiretroviral therapy. J Public Health Res. 2015; 4(2):82-89. 
 
28 
 
27. Beals K, Wight R, Aneshensel C, Murphy D, Miller-Martinez D. The role of family 
caregivers in HIV medication adherence. AIDS Care. 2006; 18:589–596. 
28. Tuhadeleni O, Nghipondoka- Lukolo  L. The perceptions of patients on antiretroviral 
therapy (ART) and treatment supporters with regard to their role towards ART 
adherence, at ART clinics in the intermediate hospital Oshakati, Namibia.  Int J Med. 
2017; 5 (1):17-21. 
29. Iroezi N, Mindr D, Kawale P, Chikowi G, Jansen P, Hoffman R. A qualitative analysis of 
the barriers and facilitators to receiving care in a prevention of mother-to-child program in 
Nkhoma, Malawi. Afr J Reprod Health. 2013; 17(4):118–129. 
30. McCoy S, Buzdugan R, Mushavi A, Mahomva A, Cowan F, Padian N. Food insecurity is 
a barrier to prevention of mother-to-child HIV transmission services in Zimbabwe: a 
cross-sectional study. BMC Public Health. 2015; 15(420):1-9.  
31. Chop E, Duggaraju A, Malley A, Burke V, Caldas S, Yeh PT et al. Food insecurity, 
sexual risk behavior, and adherence to antiretroviral therapy among women living with 
HIV: A systematic review. Health Care Women Int. 2017 Sep; 38(9):927-944. 
32. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, Kassie DM. 
Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care 
among adult HIV-positive patients: a qualitative study from Ethiopia. PLoS One. 2014 
May 14; 9(5):e97353.  
33. Bam K, Rajbhandari RM, Karmacharya DB, Dixit SM. Strengthening adherence to 
antiretroviral therapy (ART) monitoring and support: operation research to identify 
barriers and facilitators in Nepal. BMC Health Serv Res. 2015 May 5; 15:188. 
34. Hawkins T. Understanding and managing adverse effects of antiretroviral therapy. 
Antiretroviral Research. 2010; 85(1):201-9. 
35. Enwereji E, Enwereji K. Assessing factors that affect childbirth choices of people living 
positively with HIV/AIDS in Abia state of Nigeria. Oman Medical Journal. 2010; 25(2):91–
99. 
29 
 
36. Boehme A, Moneyham L, McLeod J, Walcott M, Wright L, Seal P et al. HIV-infected 
women’s relationships with their health care providers in the rural deep south: an 
exploratory study. Health Care Women Int. 2012; 33:403–419. 
37. Chochinov H. Dignity and the essence of medicine: the A, B, C, and D of dignity 
conserving care. BMJ. 2007; 335:184–187. 
38. Sampson IT. Religion and the Nigerian State: Situating the de facto and de jure Frontiers 
of State–Religion Relations and its Implications for National Security. Oxford Journal of 
Law and Religion. 2014; 3(2): 311–339. 
39. Unge C1, Ragnarsson A, Ekström AM, Indalo D, Belita A, Carter J. et al. The influence of 
traditional medicine and religion on discontinuation of ART in an urban informal 
settlement in Nairobi, Kenya. AIDS Care. 2011 Jul; 23(7):851-8. 
40. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research 
(COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 
2007; 19(6):349–357. 
